Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Underweight rating on Alignment Healthcare (NASDAQ:ALHC) but raises the price target from $4.5 to $7.
August 05, 2024 | 11:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Barclays analyst Andrew Mok maintains an Underweight rating on Alignment Healthcare but raises the price target from $4.5 to $7.
The Underweight rating suggests a bearish outlook, but the raised price target indicates some positive expectations. The mixed signals may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100